We Develop Drug Treatments Using Physics Based Modeling and Artificial Intelligence

Eniko started Verseon because she saw firsthand the lack of innovation in multiple areas of drug development. She is passionate about building and leading organizations and teams to solve hard science and technology challenges. Eniko guided Verseon through several rounds of financing and growth and shaped the company's technology platform and drug pipeline. Previously, she was the COO of Pulsent, where she wrote the core code of the company’s technology that got the company funded. Eniko is an inventor on 25 patent families. She received her BS in Physics from Universitatea Babes Bolyai in Romania.